Kevin Tan - Sep 20, 2021 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Kevin Tan
Stock symbol
SELB
Transactions as of
Sep 20, 2021
Transactions value $
$0
Form type
4
Date filed
9/22/2021, 04:19 PM
Next filing
Dec 6, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Employee Stock Option (right to buy) Award $0 +750K $0.00 750K Sep 20, 2021 Common Stock 750K $4.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest as to 25% on September 20, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.